Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 5/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.35 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6013791 | 0.81 | KDM4E (0.46) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL3776897 | 0.80 | TBXAS1 (0.46) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| Acetic Acid SCHEMBL29002166 | 0.80 | GAA (0.46) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL28900907 | 0.79 | KDM4E (0.49) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL15874710 | 0.79 | TBXAS1 (0.41) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL13377431 | 0.79 | TAAR1 (0.38) | FDPSGAASMN1; SMN2HTTALDH1A1 | |
| SCHEMBL19292211 | 0.79 | TBXAS1 (0.62) | FDPSGAASMN1; SMN2TBXAS1TAAR1 | |
| SCHEMBL2648605 | 0.78 | — | — | |
| SCHEMBL13382331 | 0.78 | TAAR1 (0.42) | FDPSTBXAS1TAAR1HTR1AL3MBTL1 | |
| SCHEMBL7866877 | 0.78 | HSD17B10 (0.50) | GAASMN1; SMN2ALDH1A1TBXAS1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137808-A1 | PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS | ALBEMARLE CORPORATION (US) | 2009-05-28 | — | — | US | disclosed |
| WO-2008157050-A1 | PROCESSES FOR MANUFACTURING BISPHOSPHONIC ACIDS | ALBEMARLE CORPORATION (US) | 2008-12-24 | — | — | WO | disclosed |
| EP-1996599-A2 | PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS | Albermarle Corporation (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007109542-A2 | PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS | ALBEMARLE CORPORATION (US) | 2007-09-27 | — | — | WO | disclosed |
| EP-0195414-B1 | 2-AZOLYLPROPIONATE DERIVATIVES AND FUNGICIDES CONTAINING THE SAME | SDS Biotech K.K. (JP) | 1991-02-27 | — | — | EP | disclosed |
| US-4767752-A | Imidazolyl or triazolyl substituted propionate derivative and nonmedical fungicide containing the same | S.D.S. BIOTECH K.K. (JP) | 1988-08-30 | — | — | US | disclosed |
| EP-0195414-A2 | 2-Azolylpropionate derivatives and fungicides containing the same | SDS Biotech K.K. (JP) | 1986-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137808-A1 | PROCESS FOR MANUFACTURING BISPHOSPHONIC ACIDS | BPGM, PGM2, GYPA | FDPS 417/4885GAA 14/4885SMN1; SMN2 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.